About
Small Molecules, Monoclonal Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodyBiotech
Team (30)
Aliene Alting
Sales & Marketing Manager
BeOne Medicines
team_member
Benjamin de Bruin
Research Associate Molecular Biology
BeOne Medicines
team_member
Devrim Tugberk
Biomedical Engineer
BeOne Medicines
team_member
Gino Turra
Head of Molecular Biology
BeOne Medicines
team_member
Heyi Zhang
Product Sales Specialist
BeOne Medicines
team_member
Iris Riswick
Scientist
BeOne Medicines
team_member
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
2
As Collaborator
5
Total Enrollment
1,346
By Phase
PHASE2: 5PHASE1: 1PHASE3: 1
By Status
RECRUITING: 2ACTIVE_NOT_RECRUITING: 2NOT_YET_RECRUITING: 1UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT06849713Collaborator
Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients With CLL or SLL
PHASE2Recruiting
40 participants
Started: May 16, 2025 · Completed: Mar 1, 2030
NCT06637501Lead Sponsor
A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
PHASE2Active, not recruiting
94 participants
Started: Nov 14, 2024 · Completed: Jun 30, 2030
NCT06568614Lead Sponsor
An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors
PHASE1Recruiting
140 participants
Started: Oct 12, 2024 · Completed: Dec 30, 2028
NCT05596097Collaborator
Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission
PHASE2Not yet recruiting
15 participants
Started: Oct 30, 2022 · Completed: Jul 30, 2026
NCT05152147Collaborator
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
PHASE3Active, not recruiting
920 participants
Started: Dec 2, 2021 · Completed: May 15, 2026
Locations (1)
Headquarters
San Carlos, CA, United States
Map
Loading map...